医疗药品|糖尿病诉讼

Wegovy®诉讼

联系律师

活跃的情况下

Wegovy® is an injectable weight-loss drug used to help overweight and obese adults with weight management. It has recently gained public attention due to shortages, off-label use and serious side effects. If you or a loved one has been harmed by the drug, 你可能有资格 file a Wegovy lawsuit.

Ozempic和Wegovy诉讼的最新进展

2月. 2, 2024

莫特利·赖斯一直站在这场诉讼的最前沿, having filed the first Wegovy lawsuit in the country alleging severe health problems caused by the drug. 律师乔纳森·奥伦特成功地为分配 Ozempic MDL到宾夕法尼亚州东区 在美国司法部监督的听证会上.S. 多地区诉讼司法事务委员会. 律师 Sara 沙发上 and Grace 钱德勒 have been featured prominently as panelists for 哈里斯·马丁2024年1月的MDL会议 关于奥兹匹克和苏波松以及其他多次会议.

什么是Wegovy?

维格维是西马鲁肽类药物的一部分. 这是一种被fda批准用于减肥的注射药物. 诺和诺德公司 developed semaglutide drugs to manage diabetes and obesity. 的y work by regulating insulin release and mimicking natural hormones that give the feeling of being full after eating a meal. 这些被称为饱腹激素. 胰高血糖素样肽1 (GLP-1)是一种饱腹激素. 

Wegovy is a GLP-1 receptor agonist (GLP-1 RA), which means it mimics the natural GLP-1 hormone. 其他GLP-1类RA药物包括西马鲁肽类药物,如 Ozempic® 和Rybelsus®. Wegovy was developed after diabetes drug testing found semaglutide drugs caused weight loss. Wegovy是糖尿病药物Ozempic的高剂量版本. 

FDA批准的药品标签 indicates usage for chronic weight management for overweight or obese adults with at least one weight-related condition. Weight-related conditions include high blood pressure, 2型糖尿病 and high cholesterol. 的 approval also indicates that Wegovy should be used in conjunction with lifestyle changes like reduced caloric intake and increased exercise.

澳门皇冠现金手机入口的政府不同于 其他西马鲁肽药物 在其剂量和批准的治疗条件. 

 

Ozempic

Wegovy

交付:

可注射的

可注射的

剂量:

从0开始.每周25毫克,连续4周. 每周增加剂量至0.4周后5毫克. 如果需要,医生可能会批准剂量增加到每周2毫克.

从0开始.每周25毫克,连续4周. 每4周增加一次剂量,直至每周总剂量为2.达到4毫克.

批准:

2型糖尿病

慢性体重管理

 

对Wegovy的担忧:标签外使用背景

Many of the publicized concerns with Ozempic stem from the drug’s popular off-label usage for weight loss. However, Wegovy is approved as a weight loss drug for certain adults and children over 12 years old. 

Off-label usage occurs when medications are used to treat conditions they are not FDA-approved for. 在一般情况下, this is a safe and accepted practice when a doctor is the one prescribing or recommending off-label usage. 

在Wegovy的案例中, off-label usage can occur when individuals who are not medically overweight or obese use it to manage weight. 因为这种药物在使用时还没有经过测试, 产生副作用的可能性可能更高.

与Wegovy有关的健康问题

Wegovy’s prescribing label highlights several potential side effects and reactions to the drug. 的se reactions were observed in clinical trials and included on the drug’s warning label:

  • 腹胀
  • 腹部疼痛
  • 急性胆囊疾病
  • 急性肾损伤
  • 急性胰腺炎
  • 过敏反应
  • 便秘
  • 腹泻
  • 头晕
  • 消化不良(消化不良)
  • 打嗝(打嗝)    
  • 乏力
  • 肠胃气胀
  • 肠胃炎
  • 胃食管反流病
  • 头疼
  • 低血糖(糖尿病患者)
  • 鼻咽炎(冷)
  • 恶心想吐
  • 甲状腺c细胞瘤
  • 呕吐

研究, consumer reports and lawsuits have highlighted other seeming side effects of semaglutide medications.

One study tied GLP-1 RAs to adverse impacts on the small intestine and blockages in the intestines and stomach. Wegovy users have also reported hospitalization due to gastroparesis (stomach paralysis), which is not included on the drug’s warning label but is believed to have caused it in some users.

这些不良事件可能很严重,甚至危及生命. Patients taking Wegovy should be sure to discuss all of these potential side effects with their doctor. 

威格维的诉讼是关于什么的?

People are filing Wegovy lawsuits after experiencing serious and unexpected side effects that they believe were caused by the drug. 例如, 2023年9月, a Pennsylvania woman represented by 五颜六色的大米 filed a lawsuit against the drug’s manufacturer, 诺和诺德公司.

诉讼详细说明了澳门皇冠现金手机入口客户的 严重的胃肠问题和随后的住院治疗 治疗胃轻瘫. This lawsuit addresses two main claims with Wegovy and its manufacturer, 诺和诺德公司.

  • 未发出警告: 的 Pennsylvania lawsuit alleges that the plaintiff experienced side effects not included on the drug’s warning label.
  • 疏忽的虚假陈述和营销: 的 lawsuit also alleges that 诺和诺德公司 misrepresented the severity of potential side effects and engaged in harmful marketing practices that targeted teens and minorities. 

除了诉讼之外 被药物伤害的人, Wegovy has also been involved in lawsuits filed by drug maker 诺和诺德公司. 的 drug manufacturer has filed lawsuits against wellness and medical spas, weight loss clinics and compounding pharmacies for selling off-brand versions of Wegovy and Ozempic.

消费者应该注意这些非品牌的版本, 哪些是未经测试的,可能会有额外的副作用.

If you or a loved one took Wegovy and experienced severe side effects like gastroparesis, 你可能有资格 提起诉讼.

Our law firm has represented and achieved recoveries for plaintiffs in personal injury lawsuits. Compensation through verdicts or settlements can help you pay for medical expenses and give you peace of mind while you recover.

有威格维的集体诉讼吗?

截至2023年10月, there is no class action drug lawsuit against 诺和诺德公司 for people harmed by Wegovy. 

One or more plaintiffs file class action lawsuits for a larger group of people, or “class.“它们可能导致巨额判决或和解裁决. People included in the class can then file to receive their share of the financial compensation.

澳门皇冠现金手机入口的医疗药品诉讼经验

Our medical attorneys have represented thousands of patients seriously hurt by dangerous prescription and over-the-counter drugs. 作为病人或家属,澳门皇冠现金手机入口理解这一点, 你对你或你所爱的人的药物的了解可能是有限的. 

如果你相信某种药会让你生病或伤害你, 澳门皇冠现金手机入口的律师拥有彻底调查所需的资源,并:

  • 识别潜在有害药物
  • 检查药物是否对你有伤害
  • 审查药品制造商是否符合FDA的规定
  • Examine the adequacy of the manufacturer's warning to you about potential side effects
  • 认识到其他可能影响你潜在索赔的问题

在这里了解更多关于澳门皇冠现金手机入口的医疗药物经验.


Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor's advice can result in injury or death.

与澳门皇冠现金手机入口合作

想知道当你提交表格或给澳门皇冠现金手机入口打电话时会发生什么? We spend time gathering information from you, and your initial call is always free.

什么是最重要的?

  • 的名字
  • 日期
  • 事件时间轴
  • 相关文档
联系律师 1.800.768.4026